Important Information

AMP 2014 Annual Meeting
AMP CELEBRATES 20 YEARS!
November 13 -15, 2014
For More Information

Corporate Workshop Day & Gala, November 12, 2014

Gaylord National Resort & Convention Center
National Harbor, MD (just outside of Washington, DC)

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP

Volunteer

AP RSS Feed Linked In FaceBook Twitter
clinical practice committee

Clinical Practice Comimittee - Comments and Projects

2009

Index of AMP Guidelines/Guidances and Position Statements & Letters (November 2009)
Comments to AHRQ Draft Report on LDTs (September 8)
Comments to House Science & Technology Committee regarding the immediate and long-term needs for standards development in biotechnology at NIST (June 2009)
Letter to Dr. Janet Woodcock encourages FDA to always identify a companion diagnostic on drug labeling by the biological description (Aug 2009)
AMP responds to Genentech Citizen Petition (April 23, 2009)
Comments on ACMG’s Technical Standards and Guidelines for Myotonic Dystrophy Type 1 Testing (January, 2009)
AMP Position on Genetic Ancestry Testing (February, 2009)
Comments to NHGRI Regarding Long Range Planning (February, 2009)

2008

Letter to the WHO endorsing reference materials for fragile X and other molecular tests.(December 2008)
Catalogue of Mutation Database Websites (November 2008)
Comments to Florida Board of Clinical Lab Personnel regarding Liscensure Requirements for Molecular Pathology Technologists (September 2008)
Comments to FDA regarding Guidance on Definitions for PGx and Sample Coding Categories (April 2008)
Comments to FDA regarding Guidance on PGx Data Submissions (April 2008)
Comments to NIGMS regarding barriers to PGx research (April 2008)
Comments to EMEA regarding Guidance on Definitions for PGx and Sample Coding Categories (March 2008)
Comments to NACB regarding Guidelines for Lab Analysis and Application of PGx to Clinical Practice (March 2008)

2007

Comments to NCI regarding Best Practices for Biospecimens (December 2007)
Comments to FDA regarding Guidance for Industry and FDA Staff: Assayed and Unassayed Quality Control Material (Docket 98D-1232) (October 2007)
Comments to FDA regarding Guidance for Industry and FDA Staff: Pharmacogenetic Tests and Genetic Tests for Heritable Markers (Docket 2006D-0012) (October 2007)
Response to The FMR1 Premutation and Premature Ovarian Failure: Worldwide Community Guideline Development (May 2007)
Comments to the CDC Proficiency Testing Work Group (March 2007)
AMP Response to HHS RFI regarding EHR (Jan 2007)

2002

Connexin 26 Working Group (Feb. 2002) (Missing File)